secwatch.observer — SEC 8-K summary
======================================

Issuer:     Coherus Oncology, Inc. (CHRS)
CIK:        0001512762
Form:       8-K
Filed at:   2025-04-22T23:59:59+00:00
Accession:  0001558370-25-005157
Event type: leadership
Sentiment:  negative
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Coherus announces CCO Paul Reider resignation effective April 30, 2025
----------------------------------------------------------------------

- Paul Reider resigned as CCO and employee effective April 30, 2025, to pursue other opportunities.
- Resignation follows completion of UDENYCA franchise divestiture; not due to any disagreement.
- Severance includes 12 months base salary and COBRA reimbursement through Dec 31, 2026.
- Vesting extended for unvested equity through Dec 31, 2026; option exercise period extended.
- Reider will advise executive leadership on a part-time basis until April 30, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1512762/000155837025005157/0001558370-25-005157-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1512762/000155837025005157/chrs-20250416x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-005157

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer